These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1334821)

  • 21. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial.
    Wiegman A; Hutten BA; de Groot E; Rodenburg J; Bakker HD; Büller HR; Sijbrands EJ; Kastelein JJ
    JAMA; 2004 Jul; 292(3):331-7. PubMed ID: 15265847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study.
    Mercuri M; Bond MG; Sirtori CR; Veglia F; Crepaldi G; Feruglio FS; Descovich G; Ricci G; Rubba P; Mancini M; Gallus G; Bianchi G; D'Alò G; Ventura A
    Am J Med; 1996 Dec; 101(6):627-34. PubMed ID: 9003110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intima media thickness of the carotid arteries: early pointer to arteriosclerosis and therapeutic endpoint].
    Ludwig M; von Petzinger-Kruthoff A; von Buquoy M; Stumpe KO
    Ultraschall Med; 2003 Jun; 24(3):162-74. PubMed ID: 12817310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relations of intimal-medial thickness among sites within the carotid artery as evaluated by B-mode ultrasound. ARIC Investigators. Atherosclerosis Risk in Communities.
    Howard G; Burke GL; Evans GW; Crouse JR; Riley W; Arnett D; de Lacy R; Heiss G
    Stroke; 1994 Aug; 25(8):1581-7. PubMed ID: 8042207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations of risk factors with segment-specific intimal-medial thickness of the extracranial carotid artery.
    Espeland MA; Tang R; Terry JG; Davis DH; Mercuri M; Crouse JR
    Stroke; 1999 May; 30(5):1047-55. PubMed ID: 10229743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carotid atherosclerosis and the risk factors in early postmenopausal Chinese women.
    Yu RH; Ho SC; Ho SS; Chan SS; Woo JL; Ahuja AT
    Maturitas; 2009 Jul; 63(3):233-9. PubMed ID: 19443144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FAST).
    Sawayama Y; Shimizu C; Maeda N; Tatsukawa M; Kinukawa N; Koyanagi S; Kashiwagi S; Hayashi J
    J Am Coll Cardiol; 2002 Feb; 39(4):610-6. PubMed ID: 11849859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation.
    Pitt B; Mancini GB; Ellis SG; Rosman HS; Park JS; McGovern ME
    J Am Coll Cardiol; 1995 Nov; 26(5):1133-9. PubMed ID: 7594023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis.
    Zanchetti A; Bond MG; Hennig M; Neiss A; Mancia G; Dal Palù C; Hansson L; Magnani B; Rahn KH; Reid J; Rodicio J; Safar M; Eckes L; Ravinetto R
    J Hypertens; 1998 Jul; 16(7):949-61. PubMed ID: 9794735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-density lipoprotein lowering and atherosclerosis progression: does more mean less?
    Shah PK
    Circulation; 2002 Oct; 106(16):2039-40. PubMed ID: 12379568
    [No Abstract]   [Full Text] [Related]  

  • 31. Stabilization of carotid atheroma assessed by quantitative ultrasound analysis in nonhypercholesterolemic patients with coronary artery disease.
    Watanabe K; Sugiyama S; Kugiyama K; Honda O; Fukushima H; Koga H; Horibata Y; Hirai T; Sakamoto T; Yoshimura M; Yamashita Y; Ogawa H
    J Am Coll Cardiol; 2005 Dec; 46(11):2022-30. PubMed ID: 16325036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reproducibility of noninvasive ultrasonic measurement of carotid atherosclerosis. The Asymptomatic Carotid Artery Plaque Study.
    Riley WA; Barnes RW; Applegate WB; Dempsey R; Hartwell T; Davis VG; Bond MG; Furberg CD
    Stroke; 1992 Aug; 23(8):1062-8. PubMed ID: 1636178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort.
    Crouse JR; Goldbourt U; Evans G; Pinsky J; Sharrett AR; Sorlie P; Riley W; Heiss G
    Stroke; 1996 Jan; 27(1):69-75. PubMed ID: 8553406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study.
    Bots ML; Palmer MK; Dogan S; Plantinga Y; Raichlen JS; Evans GW; O'Leary DH; Grobbee DE; Crouse JR;
    J Intern Med; 2009 Jun; 265(6):698-707. PubMed ID: 19298496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium antagonists and atherosclerosis. The Multicenter Isradipine/Diuretic Atherosclerosis Study.
    Furberg CD; Borhani NO; Byington RP; Gibbons ME; Sowers JR
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):24S-29S. PubMed ID: 8466723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spatial distribution of carotid intimal-medial thickness as measured by B-mode ultrasonography.
    Espeland MA; Hoen H; Byington R; Howard G; Riley WA; Furberg CD
    Stroke; 1994 Sep; 25(9):1812-9. PubMed ID: 8073462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monotherapy with HMG-CoA reductase inhibitors and secondary prevention in coronary artery disease.
    Rackley CE
    Clin Cardiol; 1996 Sep; 19(9):683-9. PubMed ID: 8874986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MIDAS: rationale, design and descriptive data of trial patients. The MIDAS Research Group.
    Borhani NO
    Blood Press Suppl; 1994; 1():29-35. PubMed ID: 8205295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of lovastatin and warfarin on early carotid atherosclerosis: sex-specific analyses. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.
    Byington RP; Evans GW; Espeland MA; Applegate WB; Hunninghake DB; Probstfield J; Furberg CD
    Circulation; 1999 Jul; 100(3):e14-7. PubMed ID: 10411862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
    Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
    JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.